Literature DB >> 22196664

Role of high-intensity focused ultrasound in treatment of hepatocellular carcinoma.

Hua-Ping Shen1, Jian-Ping Gong, Guo-Qing Zuo.   

Abstract

About 70 per cent of patients with hepatocellular carcinoma are diagnosed at intermediate or advanced stages, and most of them are technically unresectable. As a novel, emerging therapeutic modality, high intensity focused ultrasound (HIFU) has a great potential for tumor treatment. In this review, principle of HIFU technique is introduced, and an overview of clinical applications and limitations of HIFU for HCC treatment, as well as prospects for future development, is provided. Consequently, HIFU has been considered a safe and feasible procedure for HCC treatment.

Entities:  

Mesh：

Year:  2011        PMID： 22196664

Source DB:  PubMed          Journal:  Am Surg        ISSN： 0003-1348            Impact factor:   0.688


  9 in total

Review 1.  Locoregional Therapy, Immunotherapy and the Combination in Hepatocellular Carcinoma: Future Directions.

Authors:  Meaghan S Dendy; Johannes M Ludwig; Stacey M Stein; Hyun S Kim
Journal:  Liver Cancer       Date:  2019-01-16       Impact factor: 11.740

2.  Comparison of high-intensity focused ultrasound therapy and radiofrequency ablation for recurrent hepatocellular carcinoma.

Authors:  Hiroki Nishikawa; Yukio Osaki
Journal:  Hepatobiliary Surg Nutr       Date:  2013-06       Impact factor: 7.293

Review 3.  High intensity focused ultrasound, liver disease and bridging therapy.

Authors:  Luigi Mearini
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

4.  High-intensity focused ultrasound combined with hysteroscopic resection to treat retained placenta accreta.

Authors:  Jae-Seong Lee; Gi-Youn Hong; Byung-Joon Park; Hyejin Hwang; Rayon Kim; Tae-Eung Kim
Journal:  Obstet Gynecol Sci       Date:  2016-09-13

Review 5.  Diagnostic and therapeutic management of hepatocellular carcinoma.

Authors:  Francesco Bellissimo; Marilia Rita Pinzone; Bruno Cacopardo; Giuseppe Nunnari
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 6.  Comparison of percutaneous ablation technologies in the treatment of malignant liver tumors.

Authors:  Hyeon Yu; Charles T Burke
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

7.  Potential enhancement of intravenous nano-hydroxyapatite in high-intensity focused ultrasound ablation for treating hepatocellular carcinoma in a rabbit model.

Authors:  Liping Liu; Ziwen Xiao; Yanbing Xiao; Zhibiao Wang; Faqi Li; Maoping Li; Xiaoqiong Peng
Journal:  Oncol Lett       Date:  2014-02-21       Impact factor: 2.967

Review 8.  Minimally invasive local therapies for liver cancer.

Authors:  David Li; Josephine Kang; Benjamin J Golas; Vincent W Yeung; David C Madoff
Journal:  Cancer Biol Med       Date:  2014-12       Impact factor: 4.248

9.  Consensus of Minimally Invasive and Multidisciplinary Comprehensive Treatment for Hepatocellular Carcinoma - 2020 Guangzhou Recommendations.

Authors:  Qi-Feng Chen; Wang Li; Simon Chun-Ho Yu; Yi-Hong Chou; Hyunchul Rhim; Xiaoming Yang; Lujun Shen; Annan Dong; Tao Huang; Jinhua Huang; Fujun Zhang; Weijun Fan; Ming Zhao; Yangkui Gu; Zhimei Huang; Mengxuan Zuo; Bo Zhai; Yueyong Xiao; Ming Kuang; Jiaping Li; Jianjun Han; Wei Song; Jie Ma; Peihong Wu
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.